Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Acute diagnostic biomarkers for spinal cord injury: review of the literature and preliminary research report.

Yokobori S, Zhang Z, Moghieb A, Mondello S, Gajavelli S, Dietrich WD, Bramlett H, Hayes RL, Wang M, Wang KK, Bullock MR.

World Neurosurg. 2015 May;83(5):867-78. doi: 10.1016/j.wneu.2013.03.012. Epub 2013 Mar 19. Review.

2.

Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury.

Kwon BK, Stammers AM, Belanger LM, Bernardo A, Chan D, Bishop CM, Slobogean GP, Zhang H, Umedaly H, Giffin M, Street J, Boyd MC, Paquette SJ, Fisher CG, Dvorak MF.

J Neurotrauma. 2010 Apr;27(4):669-82. doi: 10.1089/neu.2009.1080.

PMID:
20038240
3.

Biomarkers for the clinical differential diagnosis in traumatic brain injury--a systematic review.

Yokobori S, Hosein K, Burks S, Sharma I, Gajavelli S, Bullock R.

CNS Neurosci Ther. 2013 Aug;19(8):556-65. doi: 10.1111/cns.12127. Epub 2013 May 27. Review.

PMID:
23710877
4.

Diagnostic Value of Serum Levels of GFAP, pNF-H, and NSE Compared With Clinical Findings in Severity Assessment of Human Traumatic Spinal Cord Injury.

Ahadi R, Khodagholi F, Daneshi A, Vafaei A, Mafi AA, Jorjani M.

Spine (Phila Pa 1976). 2015 Jul 15;40(14):E823-30. doi: 10.1097/BRS.0000000000000654.

PMID:
25341992
5.

Temporal Profile and Severity Correlation of a Panel of Rat Spinal Cord Injury Protein Biomarkers.

Yang Z, Bramlett HM, Moghieb A, Yu D, Wang P, Lin F, Bauer C, Selig TM, Jaalouk E, Weissman AS, Rathore DS, Romo P, Zhang Z, Hayes RL, Wang MY, Dietrich WD, Wang KKW.

Mol Neurobiol. 2017 Mar 13. doi: 10.1007/s12035-017-0424-7. [Epub ahead of print]

PMID:
28290147
6.

The developing landscape of diagnostic and prognostic biomarkers for spinal cord injury in cerebrospinal fluid and blood.

Hulme CH, Brown SJ, Fuller HR, Riddell J, Osman A, Chowdhury J, Kumar N, Johnson WE, Wright KT.

Spinal Cord. 2017 Feb;55(2):114-125. doi: 10.1038/sc.2016.174. Epub 2016 Dec 20. Review.

PMID:
27995945
7.

Serum biomarkers for experimental acute spinal cord injury: rapid elevation of neuron-specific enolase and S-100beta.

Loy DN, Sroufe AE, Pelt JL, Burke DA, Cao QL, Talbott JF, Whittemore SR.

Neurosurgery. 2005 Feb;56(2):391-7; discussion 391-7.

PMID:
15670387
8.

Inflammatory and structural biomarkers in acute traumatic spinal cord injury.

Kwon BK, Casha S, Hurlbert RJ, Yong VW.

Clin Chem Lab Med. 2011 Mar;49(3):425-33. doi: 10.1515/CCLM.2011.068. Epub 2010 Dec 23. Review.

PMID:
21175377
9.

Structural biomarkers in the cerebrospinal fluid within 24 h after a traumatic spinal cord injury: a descriptive analysis of 16 subjects.

Pouw MH, Kwon BK, Verbeek MM, Vos PE, van Kampen A, Fisher CG, Street J, Paquette SJ, Dvorak MF, Boyd MC, Hosman AJ, van de Meent H.

Spinal Cord. 2014 Jun;52(6):428-33. doi: 10.1038/sc.2014.26. Epub 2014 Apr 8.

PMID:
24710150
10.

Steroids for acute spinal cord injury.

Bracken MB.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD001046. doi: 10.1002/14651858.CD001046.pub2. Review.

PMID:
22258943
11.

Keeping promises: translating basic research into new spinal cord injury therapies.

Kleitman N.

J Spinal Cord Med. 2004;27(4):311-8. Review.

PMID:
15484661
13.

Neuroproteomic methods in spinal cord injury.

Chen A, Springer JE.

Methods Mol Biol. 2009;566:57-67. doi: 10.1007/978-1-59745-562-6_4.

PMID:
20058164
14.

Acute neurosurgical management of traumatic brain injury and spinal cord injury.

Gunnarsson T, Fehlings MG.

Curr Opin Neurol. 2003 Dec;16(6):717-23. Review.

PMID:
14624082
15.

Effect of estrogen on recovering the injured nervous system.

Liu Z, Mu S, Wang X.

Pak J Pharm Sci. 2015 Jul;28(4 Suppl):1471-5.

PMID:
26431647
16.

Spinal cord injury models: a review.

Cheriyan T, Ryan DJ, Weinreb JH, Cheriyan J, Paul JC, Lafage V, Kirsch T, Errico TJ.

Spinal Cord. 2014 Aug;52(8):588-95. doi: 10.1038/sc.2014.91. Epub 2014 Jun 10.

PMID:
24912546
18.

Descending motor pathways and cortical physiology after spinal cord injury assessed by transcranial magnetic stimulation: a systematic review.

Nardone R, Höller Y, Brigo F, Orioli A, Tezzon F, Schwenker K, Christova M, Golaszewski S, Trinka E.

Brain Res. 2015 Sep 4;1619:139-54. doi: 10.1016/j.brainres.2014.09.036. Epub 2014 Sep 22. Review.

PMID:
25251591
19.

Strategies for neuroprotection following spinal cord injury.

Tederko P, Krasuski M, Kiwerski J, Nyka I, Białoszewski D.

Ortop Traumatol Rehabil. 2009 Mar-Apr;11(2):103-10. Review. English, Polish.

PMID:
19502667
20.

Type I interferon inhibits astrocytic gliosis and promotes functional recovery after spinal cord injury by deactivation of the MEK/ERK pathway.

Ito M, Natsume A, Takeuchi H, Shimato S, Ohno M, Wakabayashi T, Yoshida J.

J Neurotrauma. 2009 Jan;26(1):41-53. doi: 10.1089/neu.2008.0646.

PMID:
19196180

Supplemental Content

Support Center